PHARMAYOU GLONS
0415.732.694 · rovalta.com · 24/09/2026
ACTIVE
PHARMAYOU GLONS
Financial year 2025 · closed on 31/12/2025
Net result
72,3 k €
+21.7% YoY
Gross margin
363,2 k €
+12.8% YoY
Equity
461,1 k €
+18.4% YoY
Workforce
2,0 ETP
-41.2% YoY
Overview
What does PHARMAYOU GLONS do?
PHARMAYOU GLONS is a Private limited company incorporated in 1976. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bassenge. It employs on average 2,0 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0415.732.694
Incorporation
01/01/1976
Legal form
Private limited company
Registered office
Rue Sous la Vigne 19
4690 Bassenge · WallonieSee on map
4690 Bassenge · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Average workforce
2,0 ETP
Activities (NACE)
Joint committees (1)
- 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||
| Gross margin | 363,2 k € | +12.8% | 321,9 k € | +79.0% | 179,9 k € | -28.0% | 249,9 k € | +38.2% | 180,8 k € | -20.5% | 227,3 k € | +31.9% | 172,3 k € | +12.0% | 153,8 k € | -11.2% | 173,3 k € | -7.4% | 187,2 k € | +103% | 92,2 k € | -27.9% | 128 k € | +0.4% | 127,4 k € | +17.2% | 108,7 k € | -18.0% | 132,6 k € | +55.5% | 85,3 k € | +45.7% | 58,6 k € | +113% | 27,5 k € | -4.0% | 28,6 k € |
| EBITDA | 129,6 k € | +42.0% | 91,3 k € | +400% | -30,5 k € | -122% | 141,5 k € | -9.9% | 157,1 k € | -1.8% | 160 k € | +31.0% | 122,2 k € | +32.4% | 92,3 k € | +0.1% | 92,3 k € | -26.1% | 124,9 k € | +41.2% | 88,4 k € | -26.1% | 119,7 k € | -4.9% | 125,9 k € | +18.3% | 106,4 k € | -24.1% | 140,1 k € | +47.3% | 95,1 k € | +196% | 32,1 k € | +97.7% | 16,2 k € | +11.3% | 14,6 k € |
| Operating result | 109,9 k € | +51.3% | 72,6 k € | +268% | -43,2 k € | -140% | 108,9 k € | -18.8% | 134,2 k € | +29.6% | 103,6 k € | +24.3% | 83,3 k € | +98.8% | 41,9 k € | +53.9% | 27,2 k € | -11.9% | 30,9 k € | +42.7% | 21,7 k € | -57.0% | 50,3 k € | -5.6% | 53,3 k € | +60.1% | 33,3 k € | +87.1% | 17,8 k € | +84.2% | 9,7 k € | -46.9% | 18,2 k € | +345% | 4,1 k € | +58.8% | 2,6 k € |
| Net result | 72,3 k € | +21.7% | 59,5 k € | +204% | -57,4 k € | -178% | 73,7 k € | -21.1% | 93,4 k € | +117% | 43 k € | -32.4% | 63,6 k € | +168% | 23,7 k € | +295% | 6 k € | -34.5% | 9,2 k € | +589% | -1,9 k € | -109% | 21,8 k € | -33.3% | 32,6 k € | -19.7% | 40,6 k € | +2504% | -1,7 k € | +64.8% | -4,8 k € | -125% | 19,4 k € | +102% | 9,6 k € | -56.6% | 22 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||
| Equity | 461,1 k € | +18.4% | 389,3 k € | +17.8% | 330,4 k € | -14.9% | 388,3 k € | +23.2% | 315,2 k € | +41.7% | 222,4 k € | +23.6% | 180 k € | +53.9% | 117 k € | -44.0% | 208,8 k € | +2.7% | 203,4 k € | +5.3% | 193,1 k € | -1.2% | 195,6 k € | +12.2% | 174,4 k € | +22.5% | 142,3 k € | +56.4% | 91 k € | -1.8% | 92,7 k € | -4.9% | 97,5 k € | +63.3% | 59,7 k € | +19.1% | 50,1 k € |
| Total assets | 901,8 k € | +29.0% | 699,2 k € | -14.8% | 821,1 k € | -9.0% | 902,2 k € | -0.2% | 904,4 k € | +1.5% | 891,3 k € | +20.9% | 737,4 k € | +9.7% | 672,4 k € | -25.0% | 896,8 k € | -0.4% | 900,5 k € | +3.4% | 870,7 k € | -4.5% | 911,6 k € | +0.8% | 904,7 k € | -8.5% | 988,4 k € | -9.6% | 1,1 M € | +72.0% | 635,6 k € | +87.6% | 338,8 k € | +37.0% | 247,3 k € | -7.6% | 267,5 k € |
| Cash | 244,7 k € | +36.8% | 178,8 k € | -34.0% | 271 k € | -16.7% | 325,2 k € | +1.5% | 320,3 k € | -3.7% | 332,5 k € | +41.6% | 234,7 k € | +65.0% | 142,3 k € | +23.3% | 115,4 k € | +11.2% | 103,8 k € | +36.5% | 76,1 k € | -0.7% | 76,6 k € | -24.9% | 102 k € | +164% | 38,6 k € | -1.5% | 39,2 k € | -35.7% | 60,9 k € | +166% | 22,9 k € | +119% | 10,5 k € | -1.3% | 10,6 k € |
| Debts | 440,7 k € | +42.2% | 309,9 k € | -36.8% | 490,7 k € | -4.5% | 513,8 k € | -2.9% | 529,2 k € | -8.5% | 578,5 k € | +12.9% | 512,3 k € | -3.4% | 530,2 k € | -22.3% | 682,6 k € | -1.1% | 690 k € | +3.2% | 668,9 k € | -5.0% | 704,3 k € | -1.9% | 718,3 k € | -13.5% | 830,8 k € | -17.0% | 1 M € | +87.8% | 532,9 k € | +146% | 216,3 k € | +16.4% | 185,9 k € | -12.2% | 211,7 k € |
| Other | |||||||||||||||||||||||||||||||||||||
| Workforce | 2,0 ETP | -41.2% | 3,4 ETP | -10.5% | 3,8 ETP | +81.0% | 2,1 ETP | +950% | 0,2 ETP | -75.0% | 0,8 ETP | -11.1% | 0,9 ETP | -10.0% | 1,0 ETP | 0.0% | 1,0 ETP | 0.0% | 1,0 ETP | – | – | – | – | – | – | – | 0,1 ETP | 0.0% | 0,1 ETP | ||||||||
Estimate
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 7 ended
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2026 | 31/08/2025 | 30/08/2024 | 29/08/2023 | 25/08/2022 | 31/08/2021 |
| General meeting | 30/05/2026 | 31/05/2025 | 25/05/2024 | 27/05/2023 | 28/05/2022 | 31/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/05/2026 | 31/08/2026 | French | |
| Abridged model | 31/12/2024 | 31/05/2025 | 31/08/2025 | French | |
| Abridged model | 31/12/2023 | 25/05/2024 | 30/08/2024 | French | |
| Abridged model | 31/12/2022 | 27/05/2023 | 29/08/2023 | French | |
| Abridged model | 31/12/2021 | 28/05/2022 | 25/08/2022 | French | |
| Abridged model | 31/12/2020 | 31/05/2021 | 31/08/2021 | French | |
| Abridged model | 31/12/2019 | 30/05/2020 | 22/12/2020 | French | |
| Abridged model | 31/12/2018 | 25/05/2019 | 29/08/2019 | French | |
| Abridged model | 31/12/2017 | 26/05/2018 | 30/08/2018 | French | |
| Abridged model | 31/12/2016 | 27/05/2017 | 30/08/2017 | French | |
| Abridged model | 31/12/2015 | 28/05/2016 | 31/08/2016 | French | |
| Abridged model | 31/12/2014 | 30/05/2015 | 27/08/2015 | French | |
| Abridged model | 31/12/2013 | 24/05/2014 | 26/08/2014 | French | |
| Abridged model | 31/12/2012 | 25/05/2013 | 29/08/2013 | French | |
| Abridged model | 31/12/2011 | 26/05/2012 | 29/08/2012 | French | |
| Abridged model | 31/12/2010 | 28/05/2011 | 31/08/2011 | French | |
| Abridged model | 31/12/2009 | 29/05/2010 | 26/08/2010 | French | |
| Abridged model | 31/12/2008 | 30/05/2009 | 24/08/2009 | French | |
| Abridged model | 31/12/2007 | 31/05/2008 | 02/07/2008 | French | |
| Abridged model | 31/12/2006 | 30/06/2007 | 20/07/2007 | French |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Publications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates21/02/2024MODIFICATION FORME JURIDIQUE - DENOMINATION - DEMISSIONS, NOMINATIONS
- Mandates07/10/2013DEMISSIONS, NOMINATIONS
- Mandates02/12/2011SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - DIVERS
- Mandates01/12/2008SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Capital / shares18/02/2004ASSEMBLEE GENERALE - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202572,3 k €↑
- 2024Annual accounts 202459,5 k €↑
- 2023Annual accounts 2023-57,4 k €↓
- 2023Name changePHARMAYOU GLONS
- 2022Annual accounts 202273,7 k €↓
- 2021Annual accounts 202193,4 k €↑
- 2021Name changePHARMAGEER
- 2020Annual accounts 202043 k €↓
- 2019Annual accounts 201963,6 k €↑
- 2018Annual accounts 201823,7 k €↑
- 2017Annual accounts 20176 k €↓
- 2016Annual accounts 20169,2 k €↑
- 2015Annual accounts 2015-1,9 k €↓
- 2014Annual accounts 201421,8 k €↓
- 2013Annual accounts 201332,6 k €↓
- 2012Annual accounts 201240,6 k €↑
- 2011Annual accounts 2011-1,7 k €↑
- 2010Annual accounts 2010-4,8 k €↓
- 2009Annual accounts 200919,4 k €↑
- 2007Annual accounts 20079,6 k €↓
- 2006Annual accounts 200622 k €
- 01/01/1976IncorporationPrivate limited company